Search Results - "Winters, Brett R"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Standardization of the collection of exhaled breath condensate and exhaled breath aerosol using a feedback regulated sampling device by Winters, Brett R, Pleil, Joachim D, Angrish, Michelle M, Stiegel, Matthew A, Risby, Terence H, Madden, Michael C

    Published in Journal of breath research (01-11-2017)
    “…Exhaled breath condensate (EBC) and associated exhaled breath aerosols (EBA) are valuable non-invasive biological media used for the quantification of…”
    Get more information
    Journal Article
  2. 2

    Impact of E‑Cigarette Liquid Flavoring Agents on Activity of Microsomal Recombinant CYP2A6, the Primary Nicotine-Metabolizing Enzyme by Winters, Brett R, Kochar, Tavleen K, Clapp, Phillip W, Jaspers, Ilona, Madden, Michael C

    Published in Chemical research in toxicology (20-07-2020)
    “…Nicotine is the primary psychoactive chemical in both traditional and electronic cigarettes (e-cigarettes). Nicotine levels in both traditional cigarettes and…”
    Get full text
    Journal Article
  3. 3

    Innovative approaches to cardiovascular safety pharmacology assessment by Pugsley, Michael K., Winters, Brett R., Koshman, Yevgeniya E., Authier, Simon, Foley, C. Michael, Hayes, Eric S., Curtis, Michael J.

    “…This editorial prefaces the annual themed issue on safety pharmacology (SP) methods which has been published since 2004 in the Journal of Pharmacological and…”
    Get full text
    Journal Article
  4. 4

    Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document by Pugsley, Michael K., Koshman, Yevgeniya E., Foley, C. Michael, Winters, Brett R., Authier, Simon, Curtis, Michael J.

    “…This editorial prefaces the annual themed issue on safety pharmacology (SP) methods published since 2004 in the Journal of Pharmacological and Toxicological…”
    Get full text
    Journal Article
  5. 5

    Safety pharmacology in 2022: Taking one small step for cardiovascular safety assay development but one giant leap for regulatory drug safety assessment by Pugsley, Michael K., Koshman, Yevgeniya E., de Korte, Tessa, Authier, Simon, Winters, Brett R., Curtis, Michael J.

    “…The 2021 Annual Safety Pharmacology (SP) Society (SPS) meeting was held virtually October 4–8, 2021 due to the continuing COVID-19 global pandemic. This themed…”
    Get full text
    Journal Article
  6. 6

    Chicken Corneocyte Cross-Linked Proteome by Rice, Robert H, Winters, Brett R, Durbin-Johnson, Blythe P, Rocke, David M

    Published in Journal of proteome research (01-02-2013)
    “…Shotgun proteomic analysis was performed of epidermal scale, feather, beak and claw from the domestic chicken. To this end, the samples were separated first…”
    Get full text
    Journal Article
  7. 7

    E‑Cigarette Liquids and Aldehyde Flavoring Agents Inhibit CYP2A6 Activity in Lung Epithelial Cells by Winters, Brett R., Clapp, Phillip W., Simmons, Steven O., Kochar, Tavleen K., Jaspers, Ilona, Madden, Michael C.

    Published in ACS omega (28-03-2023)
    “…Certain e-liquids and aromatic aldehyde flavoring agents were previously identified as inhibitors of microsomal recombinant CYP2A6, the primary…”
    Get full text
    Journal Article
  8. 8

    Exhaled breath condensate biomarkers in critically ill, mechanically ventilated patients by Davis, Michael D, Winters, Brett R, Madden, Michael C, Pleil, Joachim D, Sessler, Curtis N, Wallace, M Ariel Geer, Ward-Caviness, Cavin K, Montpetit, Alison J

    Published in Journal of breath research (01-01-2021)
    “…Pneumonia is a significant risk for critically ill, mechanically ventilated (CIMV) patients. Diagnosis of pneumonia generally requires a combination of…”
    Get more information
    Journal Article